Legal & General Group
BLFS icon

Legal & General Group’s BioLife Solutions BLFS Stock Holding History

Legal & General Group’s Portfolio BLFS Stock Details BLFS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.62M Sell
92,631
-4,578
-5% -$107K ﹤0.01% 1861
2026
Q1 		$1.85M Sell
97,209
-7,805
-7% -$173K ﹤0.01% 1936
2025
Q4 		$2.54M Sell
105,014
-3,893
-4% -$102K ﹤0.01% 1878
2025
Q3 		$2.78M Buy
108,907
+3,312
+3% +$78.6K ﹤0.01% 1849
2025
Q2 		$2.27M Buy
105,595
+10,001
+10% +$225K ﹤0.01% 1922
2025
Q1 		$2.18M Sell
95,594
-2,958
-3% -$77.9K ﹤0.01% 1892
2024
Q4 		$2.56M Buy
98,552
+640
+0.7% +$15.9K ﹤0.01% 1869
2024
Q3 		$2.45M Sell
97,912
-4,629
-5% -$109K ﹤0.01% 1885
2024
Q2 		$2.2M Sell
102,541
-405
-0.4% -$7.86K ﹤0.01% 1904
2024
Q1 		$1.91M Buy
102,946
+849
+0.8% +$14.8K ﹤0.01% 1963
2023
Q4 		$1.66M Buy
102,097
+380
+0.4% +$4.85K ﹤0.01% 2032
2023
Q3 		$1.4M Sell
101,717
-585
-0.6% -$9.22K ﹤0.01% 2054
2023
Q2 		$2.26M Buy
102,302
+20,260
+25% +$427K ﹤0.01% 1868
2023
Q1 		$1.78M Sell
82,042
-970
-1% -$21.8K ﹤0.01% 1927
2022
Q4 		$1.51M Buy
83,012
+2,282
+3% +$47.1K ﹤0.01% 1998
2022
Q3 		$1.84M Buy
80,730
+1,854
+2% +$39.7K ﹤0.01% 1895
2022
Q2 		$1.09M Buy
78,876
+11,762
+18% +$173K ﹤0.01% 2134
2022
Q1 		$1.53M Buy
67,114
+504
+0.8% +$13.3K ﹤0.01% 2093
2021
Q4 		$2.48M Buy
66,610
+1,286
+2% +$55.2K ﹤0.01% 1924
2021
Q3 		$2.77M Buy
65,324
+61,215
+1,490% +$2.95M ﹤0.01% 1867
2021
Q2 		$183K Buy
4,109
+1,408
+52% +$49.6K ﹤0.01% 2556
2021
Q1 		$97K Sell
2,701
-56
-2% -$2.21K ﹤0.01% 2628
2020
Q4 		$110K Buy
2,757
+1,123
+69% +$38.3K ﹤0.01% 2560
2020
Q3 		$47K Buy
1,634
+524
+47% +$11.3K ﹤0.01% 2712
2020
Q2 		$18K Hold
1,110
– – ﹤0.01% 3100
2020
Q1 		$11K Sell
1,110
-252
-19% -$3.46K ﹤0.01% 3126
2019
Q4 		$22K Buy
1,362
+256
+23% +$4.16K ﹤0.01% 3150
2019
Q3 		$18K Hold
1,106
– – ﹤0.01% 3164
2019
Q2 		$19K Buy
+1,106
New +$19.3K ﹤0.01% 3208

Other funds holding BLFS

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Legal & General Group's BLFS Position: Q2 2026 in Review

Legal & General Group reduced its BioLife Solutions (BLFS) stake by 4.7% in Q2 2026, selling an estimated $107K and leaving 92,631 shares worth $2.62M. The position accounts for ﹤0.01% of the portfolio, ranked #1861.

Legal & General Group first reported a position in BLFS in Q2 2019 and has held it in 29 quarters since. The position peaked at $2.78M in Q3 2025. 216 funds tracked by Wall St. Rank hold BLFS as of Q2 2026.

  • Legal & General Group held 92,631 shares of BioLife Solutions worth $2.62M as of Q2 2026.
  • Legal & General Group sold 4,578 BioLife Solutions shares in Q2 2026, an estimated $107K.
  • BioLife Solutions made up ﹤0.01% of Legal & General Group's portfolio in Q2 2026, its #1861 holding.
  • Legal & General Group first reported a position in BioLife Solutions in Q2 2019 and has held it in 29 quarters since.
  • Legal & General Group's BioLife Solutions position peaked at $2.78M in Q3 2025.
  • 216 funds tracked by Wall St. Rank held BioLife Solutions as of Q2 2026.

Based on Legal & General Group's 13F filing for Q2 2026, filed 14 Aug 2026.